Clinical Study for the Treatment of Breast Cancer: the Patient Will Receive Afatinib Plus Letrozole or Letrozole Alone
Status:
Terminated
Trial end date:
2018-11-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to compare the efficacy of treatment with afatinib plus letrozole
to treatment with letrozole alone in women diagnosed with a specific type of breast cancer.